N-((6-Chloropyridazin-3-yl)methyl)cyclopropanamine

Catalog No. :
ACJYNZ826
CAS No. :
1289386-54-4
Molecular Formula :
C8H10ClN3
Molecular Weight :
183.64

IUPAC Name:N-((6-chloropyridazin-3-yl)methyl)cyclopropanamine

N-((6-Chloropyridazin-3-yl)methyl)cyclopropanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$93.00Login to see priceInquiryInquiry
1g95%$210.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((6-Chloropyridazin-3-yl)methyl)cyclopropanamine
IUPAC NameN-((6-chloropyridazin-3-yl)methyl)cyclopropanamine
MDL No.MFCD18837140
Molecular FormulaC8H10ClN3
Molecular Weight183.64
SMILESClC1=NN=C(CNC2CC2)C=C1
InChI KeyKSOUYMJPPURPOA-UHFFFAOYSA-N
Synonym(6-Chloro-pyridazin-3-ylmethyl)-cyclopropyl-amine;N-((6-chloropyridazin-3-yl)Methyl)cyclopropanaMine;N-((6-Chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride;[(6-Chloropyridazin-3-yl)Methyl]cyclopropylaMine hydrochloride;6-Chloro-N-cyclopropyl-3-pyridazinemethanamine;(6-Chloro-pyridazin-3-ylmethyl)-cyclopropyl-amine ISO 9001:2015 REACH;3-Pyridazinemethanamine, 6-chloro-N-cyclopropyl-
CAS No.1289386-54-4

Synthetic Route by SureRoute

1. ACJYNZ826 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  2. Plus
  3. ACJRPB365 route compound structure diagram
    ACJRPB365303085-53-2 In Stock
  4. Then
  5. ACJYNZ826 route product structure diagram
    ACJYNZ8261289386-54-4
Inquiry

2. ACJYNZ826 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACASRE367 route compound structure diagram
    ACASRE367120276-59-7 In Stock
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Then
  5. ACJYNZ826 route product structure diagram
    ACJYNZ8261289386-54-4
Inquiry

Comments (0)